Becton Dickinson (BDX)
Exchange: New York Stock Exchange
Currency: USD
Price: 0.00 ()
Summary
52 Week range | 200d Moving Avg. | Beta |
0.00 – 0.00 | 0.00 | 0.00 |
Dividend | Dividend Yield | Ex-Dividend date |
0.00 | 0.00% | 0000-00-00 |
P/E Ratio | Latest EPS | DGR 3 years |
45.51 | 0.41 | 3.62% |
Overvalued
Low
N.A.
High
Slow
Dividend Growth
Fast
Profile
Becton, Dickinson & Co. is a global medical technology company. The company is engaged in the development, manufacture and sale of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. The company operates through two worldwide business segments: BD Medical and BD Life Sciences. The BD Medical segment produces medical devices that are used in healthcare settings. This segment product includes needles, syringes and intravenous catheters for medication delivery; prefilled IV flush syringes; syringes and pen needles for the self-injection of insulin and other drugs used in the treatment of diabetes. The BD Life Sciences segment produces products for the safe collection and transport of diagnostic specimens, as well as instruments and reagent systems to detect a broad range of infectious diseases, healthcare-associated infections and cancers. The segment also produces research and clinical tools that facilitate the study of cells, and the components of cells, to gain a better understanding of normal and disease processes. The principal products and services in the Life Sciences segment include integrated systems for specimen collection; safety-engineered blood collection products and systems; automated blood culturing and tuberculosis culturing systems; molecular testing systems for infectious diseases and women’s health; microorganism identification and drug susceptibility systems; liquid-based cytology systems for cervical cancer screening; rapid diagnostic assays; microbiology laboratory automation; plated media; fluorescence-activated cell sorters and analyzers; monoclonal antibodies and kits for performing cell analysis; reagent systems for life science research; molecular indexing and next-generation sequencing sample preparation for genomics research; clinical oncology, immunology and transplantation diagnostic/monitoring reagents and analyzers; and cell culture media supplements for biopharmaceutical manufacturing. Becton, Dickinson & Co. was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.
Sector: | Industry: | |
Health Technology | Medical Specialties | |
Total ESG Score
34 – 65 percentile
Environment
5 – 5 percentile
Social
20 – 5 percentile
Governance
14 – 5 percentile
Controversy level
3
MSCI ESG-Rating
BBB
see MSCI ESG rating explained
Peers
– Cardinal Health Inc. (CAH)
– AbbVie Inc. (ABBV)
– Abbott Laboratories (ABT)
– Medtronic plc (MDT)
– Johnson & Johnson (JNJ)
– West Pharmaceutical Services, Inc (WST)
Dividend Safety Metrics
Latest EPS | 0.41 | |
Annual Payout | 0.00 | |
Payout Ratio | 0.00% | |
Dividend growth | 47 Years | |
Dividend Score | 71 | |
Dividend Coverage Ratio | 0.00 | |
Altman-Z score | 2.08 | Grey Zone |
Estimated Future Total Return Metrics
Total return last 5Y | 8.90% | |
Dividend growth 5Y | 4.39% | |
Current dividend yield | 0.00% | |
Average dividend yield last 5Y | 1.29% | |
Estimated EPS growth next 5Y | 11.70% | |
Extra return due to over/under valuation | -100.00% | |
Estimated future return 5Y (CAGR) | -87.10% |
Becton Dickinson (BDX) Valuation
Becton Dickinson current dividend yield of 0.00% is -100% below its 5-year average. The 5-year average dividend yield is 1.29% (see red-line in chart). This indicates the stock looks overvalued today.
Becton Dickinson (BDX) Performance
The chart below displays the total price return(%) of Becton Dickinson for different periods:
Becton Dickinson (BDX) Total Return
The chart below displays the (CAGR) total return (%) including all dividends paid of Becton Dickinson for different periods:
Dividend Scorecard
Dividend Yield (TTM) | Annual Payout | Payout Ratio | Dividend growth |
0.00 | 0.00 | 0.00% | 47 Years |
Dividend Growth Summary
3 Year Growth Rate (CAGR) | 3.62% |
5 Year Growth Rate (CAGR) | 4.39% |
10 Year Growth Rate (CAGR) | 7.18% |
Dividend Growth Rates History
Year | Payout Amount | Annual Payout Growth (YoY) |
---|---|---|
2022 | 0.870 | -74.1% |
2021 | 3.360 | 5.0% |
2020 | 3.200 | 3.2% |
2019 | 3.100 | 2.6% |
2018 | 3.020 | 2.7% |
2017 | 2.940 | 8.5% |
2016 | 2.710 | 10.2% |
2015 | 2.460 | 10.1% |
2014 | 2.235 | 10.1% |
2013 | 2.030 | 10.0% |
2012 | 1.845 | 9.8% |
2011 | 1.680 | 10.5% |
2010 | 1.520 | 11.8% |
2009 | 1.360 | 14.8% |
2008 | 1.185 | 16.2% |
Becton Dickinson (BDX) Dividend Payment History